KORSANT PHILIP B 4
4 · IMMUNOGEN INC · Filed Jul 31, 2009
Insider Transaction Report
Form 4
IMMUNOGEN INCIMGN
SAMANA CAPITAL, L.P.
10% Owner
Transactions
- Sale
Common Stock
2009-07-31$8.64/sh−3,500,000$30,240,000→ 5,525,200 total
Footnotes (2)
- [F1]This statement is being filed by Samana Capital, L.P. ("Samana Capital"), Morton Holdings, Inc. ("Morton Holdings") and Philip B. Korsant ("Korsant" and collectively with Samana Capital and Morton Holdings, the "Reporting Persons"). Morton Holdings is the general partner of Samana Capital. Korsant is the sole shareholder of Morton Holdings. (Due to SEC formatting limitations, please see continuation in footnote 2)
- [F2](Continued from footnote 1) Samana Capital is the owner of record of all of the shares of ImmunoGen, Inc. common stock, par value $0.01 per share ("Common Stock"), reported above. The Reporting Persons may each be deemed to have or share voting or investment power over 4,312,500 shares of the Common Stock reported in Column 5 above, but do not have or share voting or investment power above the remaining 1,212,700 shares of Common Stock reported in Column 5 above. Each of the Reporting Persons disclaims beneficial ownership of the shares of Common Stock reported herein, except to the extent of its respective pecuniary interests.